News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
equipo Asabys
Asabys Announces a New Life Sciences Fund Following Its Selection in the CDTI and EIF Innvierte Deep Start Initiative
Healthcare · Industrial biotechnology · Financing
Asabys launches a fund of up to €120M to transform scientific discoveries into innovative…
Partners - Asabys Partners
ORYZON anuncia sus resultados y avances en el primer trimestre de 2026
ORYZON reports financial results and corporate update for quarter ended March 31st, 2026
Healthcare · Drug discovery · Innovative drugs
Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100%…
Partners - Oryzon Genomics
VIVEbiotech_Zelluna Partnership
VIVEbiotech and Zelluna Partnership to Advance Off-the Shelf TCR-NK Cell Therapy with GMP Lentiviral Vectors
Healthcare · Innovative drugs · Advanced therapies
Partnership during the last 8 years leverages VIVEbiotech’s decade of experience manufacturing GMP…
Partners - VIVEbiotech
Noticia VIVEBiotech
VIVEbiotech Expands Lentiviral Vector Manufacturing Capabilities with EvoLVcell
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of…
Partners - VIVEbiotech
Sede en Bruselas de la Comisión Europea
AseBio calls for a Biotech Act I with greater funding, regulatory agility, and a stronger industrial vision
Healthcare · Agrifood · Industrial biotechnology · Financing
We welcome the Biotech Act I, but believe its ambition and level of specificity must be…
Lorena Carmona Rodríguez
#NewAseBioMember | "AseBio is a key meeting point for the Spanish biotechnology ecosystem, acting as a platform for representation, collaboration, and connection between companies, institutions, and stakeholders across the sector"
Corporate
Meet StablePharma, our new member. We spoke with Lorena Carmona Rodríguez, Lab…
AseBio - STABLEPHARMA
Rubén Pérez-Mañanes
Rubén Pérez-Mañanes: “A public hospital can sustain a regulated, multidisciplinary and scientifically productive manufacturing unit without compromising its healthcare mission”
Healthcare · Access to innovation · Personalized medicine
Rubén Pérez-Mañanes is an orthopaedic oncology surgeon at the HGUGM (Gregorio Marañón University…
Partners - GENESIS Biomed
ORYZON presentará datos clínicos positivos actualizados de iadademstat en leucemia mieloide aguda en EHA 2026
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
Healthcare · Drug discovery · Innovative drugs
In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and…
Partners - Oryzon Genomics
FiCAT
For the first time, four therapeutic genes have been inserted and one ‘unwanted’ gene removed from the DNA of preclinical models in a single intervention
Healthcare · Personalized medicine · Advanced therapies
These results come from a preclinical study conducted by the Cell Engineering team at Integra…
Partners - Integra Therapeutics S.L.